References

  1. Bonnet F, Morlat P, Chêne G, Mercié P, Neau D, Chossat I. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med. 2002; 3(3):195-9. PubMed | Google Scholar

  2. Etard J, Ndiaye I, Thierry-Mieg M, Guèye N, Guèye P, Lanièce I . Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS Lond Engl. 2006; 20(8):1181-9. PubMed | Google Scholar

  3. Teklay G, Legesse B, Legesse M. Adverse Effects and Regimen Switch among Patients on Antiretroviral Treatment in a Resource Limited Setting in Ethiopia. J Pharmacovigilance. 2013; 1(4): 115. PubMed | Google Scholar

  4. Hogg R, Yip B, Kully C, Craib p, O?Shaughnessy v, Schechter T, Montaner G. Improved survival among HIV-infected patients after initiation of triple-drug anti-retroviral regimens. CMAJ. 1999; 160(5):659-665. PubMed | Google Scholar

  5. WHO/UNAIDS. Report on the global AIDS epidemic, treatment and care. WHO/UNAIDS. 2006. Google Scholar

  6. FMOH and HAPCO. ART update in Ethiopia. FMOH and HAPCO. 1998. PubMed | Google Scholar

  7. Hogan D, Salomon J et al. Prevention and treatment of HIV/AIDS in resource limited settings. Bulletin of WHO, Geneva. 2005; 83(2). PubMed | Google Scholar

  8. Ammassari A, PaolaTrotta M, Mul R. Correlates and Predictors of Adherence to HAART. JAIDS. 2005; 31(3): S123-S127. PubMed | Google Scholar

  9. FMOH. Disease Prevention and Control Department, AIDS in Ethiopia, 6th Edition, Addis Ababa. FMOH. 2006. Google Scholar

  10. Shah I. Adverse effects of antiretroviral therapy in HIV-1 infected children. J Trop Pediatr. 2006; 52(4):244-8. PubMed | Google Scholar

  11. Montessori V. Adverse effects of antiretroviral therapy for HIV infection. Canadian Medical Association Journal. 2004; 170 (2): 229-238. PubMed | Google Scholar

  12. Brinkman K, Smeitink JA, Romijn JA, Reiss P. Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet. 1999; 354(9184):1112-5. PubMed | Google Scholar

  13. Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in large urban clinic: risk factors for neurologic failure and adverse drug reaction. Ann Intern Med. 1999; 131(2):81-7. PubMed | Google Scholar

  14. Federal Democratic Republic of Ethiopia-Ministry of Health. Harari region Health Sector Development Program IV (2010/11-2014/15) plan Zero draft, Harar. Federal Democratic Republic of Ethiopia-Ministry of Health. 2010. PubMed | Google Scholar

  15. Habtegiorgis A, Gebreyesus S, Mulugeta E. Evaluation of antiretroviral treatment in two private medical centers in Addis Ababa. Ethiop Med J. 2003; 41(4):345-51. PubMed | Google Scholar

  16. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. World Health Organization. 2006. Google Scholar

  17. Modayil R, Harugeri A, Parthasarathi G, Ramesh M, Prasad R, Naik V, Giriyapura V. Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India. Pharmacoepidemiology and Drug Safety. 2010; 19(3):247-55. PubMed | Google Scholar

  18. Luma HN, Doualla MS, Choukem SP, Temfack1 E, Ashuntantang G, Joko1 HA, Koulla-Shiro S. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan African Medical Journal.2012; 12:87. PubMed | Google Scholar

  19. Tadesse TW, Mekonnen BA, Tesfaye HW, Tadesse TY. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study. BMC Pharmacology and Toxicology.2014; 15:32. PubMed | Google Scholar

  20. Masenyetse L, Manda S, Mwambi H. An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa. AIDS Research and Therapy. 2015; 12:6. PubMed | Google Scholar

  21. Agu KA, Oparah AC. Adverse drug reactions to antiretroviral therapy: Results from spontaneous reporting system in Nigeria. Perspect Clin Res. 2013; 4(2): 117-124. PubMed | Google Scholar

  22. Sharma A, Vora R, Modi M. Adverse effects of antiretroviral treatment. Indian J Dermatol Venereol Leprol. 2008; 74(3):234-7. PubMed | Google Scholar

  23. Marfatia Y, Smita M. Adverse Drug Reactions (ADR) due to Anti-retrovirals (ARV): Issues and Challenges. Indian J Sex Transm Dis. 2005; 26(1-2):40-49. PubMed | Google Scholar

  24. WHO. Patient evaluation and antiretroviral treatment for adults and adolescents, clinical Protocol for the WHO European Region (2012 revision). World Health Organization. 2012. Google Scholar

  25. Chang KH, Kim JM, Song YG, Hong SK, Lee HC, Lim SK. Does race protect an oriental population from developing lipodystrophy in HIV-infected individuals on HAART? The Journal of Infection. 2002; 44(1):33-8. Google Scholar

  26. Wester CW. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes. 2007; 46(3):318-22. PubMed | Google Scholar

  27. Van Griensven J, De Naeyer L, Mushi T, Ubarijoro S, Gashumba D, Gazille C, Zachariah R. High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007; 101(8):793-8. PubMed | Google Scholar

  28. Abdissa SG, Fekade D, Feleke Y, Seboxa T, Diro E. Adverse drug reactions associated with antiretroviral treatment among adult Ethiopian patients in a tertiary hospital. Ethiop Med J. 2012; 50(2):107-13. PubMed | Google Scholar

  29. Nuesch R, Srasuebku P, Ananworanich J, Ruxrungtham K, Phanuphak P, Duncombe C. Monitoring the toxicity of antiretroviral therapy in resource limited settings: a prospective clinical trial cohort in Thailand. Journal of Antimicrobial Chemotherapy. 2006; 58:637-644. PubMed | Google Scholar